Cell Line Genetics, Inc

Belkins
Cell Line Genetics, Inc,(CLG) is the leading independent provider of multi-species Quality Assurance services and products for the Regenerative Medicine market. Headquartered in Madison, Wisconsin and with offices in New York City, CLG’s clients include leading universities and research institutes, as well as biotechnology and pharmaceutical companies.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

cnbctv18 | May 21, 2020

news image

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More

TETRA BIO-PHARMA ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH MAKSCIENTIFIC

Send Press Releases with GlobeNewswire | February 27, 2020

news image

Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has signed a co-development definite agreement with MAKScientific. This agreement provides Tetra with access to novel patented new molecules with CB1 and CB2 agonist or antagonist properties. In the long term, this agreement secures patented new drug candidates for Tetra to develop after Caumz and QIXLEEF receive marketing approval. MAKScientific is a recognized ...

Read More

RESEARCH

BIOGNOSYS LAUNCHES NEXT-GENERATION BLOOD BIOMARKER DISCOVERY SOLUTION

Biognosys | November 10, 2021

news image

Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. The service is designed to help researchers decipher the complexity of the blood proteome and unlock unbiased discoveries for pharma and diagnostics development and precision medicine. The launch will feature a series of events and resources that detail the science and t...

Read More

CANNABIS INDUSTRY GIANT WAYOFLEAF.COM EXPANDS HEALTH-SPECIFIC CONTENT, INTRODUCES MEDICAL REVIEW TEAM

Prnewswire | September 30, 2020

news image

In a bid to improve the quality and availability of information on health-specific cannabis use, industry giant WayofLeaf.com has introduced a team of doctors and health experts to review thousands of topics relating to the use of medical cannabis and CBD for specific health conditions. The website, which for years has provided a reliable informational resource for medical cannabis patients, believes it is time for cannabis users of all types to have access to trustworthy, research-backed conten...

Read More

cnbctv18 | May 21, 2020

news image

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More

Send Press Releases with GlobeNewswire | February 27, 2020

news image

TETRA BIO-PHARMA ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH MAKSCIENTIFIC

Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has signed a co-development definite agreement with MAKScientific. This agreement provides Tetra with access to novel patented new molecules with CB1 and CB2 agonist or antagonist properties. In the long term, this agreement secures patented new drug candidates for Tetra to develop after Caumz and QIXLEEF receive marketing approval. MAKScientific is a recognized ...

Read More

RESEARCH

Biognosys | November 10, 2021

news image

BIOGNOSYS LAUNCHES NEXT-GENERATION BLOOD BIOMARKER DISCOVERY SOLUTION

Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. The service is designed to help researchers decipher the complexity of the blood proteome and unlock unbiased discoveries for pharma and diagnostics development and precision medicine. The launch will feature a series of events and resources that detail the science and t...

Read More

Prnewswire | September 30, 2020

news image

CANNABIS INDUSTRY GIANT WAYOFLEAF.COM EXPANDS HEALTH-SPECIFIC CONTENT, INTRODUCES MEDICAL REVIEW TEAM

In a bid to improve the quality and availability of information on health-specific cannabis use, industry giant WayofLeaf.com has introduced a team of doctors and health experts to review thousands of topics relating to the use of medical cannabis and CBD for specific health conditions. The website, which for years has provided a reliable informational resource for medical cannabis patients, believes it is time for cannabis users of all types to have access to trustworthy, research-backed conten...

Read More